Document:

EX-10.2

 Exhibit 10.2 

REGISTRATION RIGHTS AGREEMENT 

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 19, 2020, is entered into by and between
UNUM THERAPEUTICS INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”).
Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise
modified from time to time, the “Purchase Agreement”). 
 WHEREAS: 

A. Upon the terms and subject to the conditions of the Purchase Agreement, (i) the Company has agreed to issue to the Investor, and the
Investor has agreed to purchase, up to Twenty-Five Million Dollars ($25,000,000) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), pursuant to Section 2 of the Purchase Agreement (such shares,
the “Purchase Shares”), and (ii) the Company has agreed to issue to the Investor such number of shares of Common Stock as is required pursuant to Section 5(e) of the Purchase Agreement (the “Commitment
Shares”); and 
 B. To induce the Investor to enter into the Purchase Agreement, the Company has agreed to provide certain
registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities Act”), and applicable state securities laws. 

NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows: 
 1. DEFINITIONS.

 For purposes of this Agreement, the following terms shall have the following meanings: 

(a) “Register,” “Registered,” and “Registration” refer to a registration effected by
preparing and filing one or more registration statements of the Company in compliance with the Securities Act and providing for offering securities on a continuous basis, and the declaration or ordering of effectiveness of such registration
statement(s) by the SEC. 
 (b) “Registrable Securities” means the Purchase Shares that may from time to time be issued or
issuable to the Investor upon purchases of the Available Amount under the Purchase Agreement (without regard to any limitation or restriction on purchases), the Commitment Shares issued or issuable to the Investor, and any Common Stock issued or
issuable with respect to the Purchase Shares, the Commitment Shares or the Purchase Agreement as a result of any stock split, stock dividend, recapitalization, exchange or similar event, without regard to any limitation on purchases under the
Purchase Agreement. 
 (c) “Registration Statement” means the Shelf Registration Statement and any other registration
statement of the Company that Registers Registrable Securities, including a New Registration Statement, as amended when each became effective, including all documents filed as part thereof or incorporated by reference therein, and including any
information contained in a Prospectus subsequently filed with the SEC. 

 (d) “Shelf Registration Statement” means the Company’s existing
registration statement on Form S-3 (File No. 333- 230678). 
 2. REGISTRATION. 

(a) Mandatory Registration. The Company agrees that it shall, within the time required under Rule 424(b) under the Securities Act, file
with the SEC the Initial Prospectus Supplement pursuant to Rule 424(b) under the Securities Act specifically relating to the transactions contemplated by, and describing the material terms and conditions of, the Transaction Documents, containing
information previously omitted at the time of effectiveness of the Registration Statement in reliance on Rule 430B under the Securities Act, and disclosing all information relating to the transactions contemplated hereby required to be disclosed in
the Registration Statement and the Prospectus as of the date of the Initial Prospectus Supplement, including, without limitation, information required to be disclosed in the section captioned “Plan of Distribution” in the Prospectus. The
Investor acknowledges that it will be identified in the Initial Prospectus Supplement as an underwriter within the meaning of Section 2(a)(11) of the Securities Act. The Company shall permit the Investor to review and comment upon the Initial
Prospectus Supplement at least two (2) Business Days prior to their filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon the Initial
Prospectus Supplement within one (1) Business Day from the date the Investor receives the final pre-filing draft version thereof from the Company. The Investor shall furnish to the Company such
information regarding itself, the Securities held by it and the intended method of distribution thereof, including any arrangement between the Investor and any other Person relating to the sale or distribution of the Securities, as shall be
reasonably requested by the Company in connection with the preparation and filing of the Initial Prospectus Supplement, and shall otherwise cooperate with the Company as reasonably requested by the Company in connection with the preparation and
filing of the Initial Prospectus Supplement with the SEC. 
 (b) Effectiveness. The Company shall use its reasonable best efforts to
keep the Registration Statement effective under the Securities Act (including through any necessary renewals), and to keep the Registration Statement and the Prospectus current and available (including through any necessary renewals) for issuances
and sales of all possible Registrable Securities by the Company to the Investor, and for the resale of all of the Registrable Securities by the Investor, at all times until the earlier of (i) the date on which the Investor shall have sold all
the Registrable Securities and no Available Amount remains and (ii) 180 days following the earlier of (A) the Maturity Date and (B) the date of termination of the Purchase Agreement (the “Registration Period”). Without
limiting the generality of the foregoing, during the Registration Period, the Company shall (a) use its reasonable best efforts to cause the Common Stock to continue to be Registered as a class of securities under Section 12(b) of the
Exchange Act and shall not take any action or file any document (whether or not permitted by the Exchange Act) to terminate or suspend such registration and (b) file or furnish on or before their respective due dates all reports and other
documents required to be filed or furnished by the Company pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act, and shall not take any action or file any document (whether or not permitted by the Exchange
Act) to terminate or suspend its reporting and filing obligations under the Exchange Act. The Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading. 

(c) Prospectus Amendments or Supplements. Except as provided in this Agreement and other than periodic and current reports required to
be filed pursuant to the Exchange Act, the Company shall not file with the SEC any amendment to the Registration Statement or any supplement to the Base Prospectus that refers to the Investor, the Transaction Documents or the transactions
contemplated thereby (including, without limitation, any Prospectus Supplement filed in connection with the transactions 

  
 2 

 
contemplated by the Transaction Documents), in each case with respect to which (a) the Investor shall not previously have been advised and afforded the opportunity to review and comment
thereon at least two (2) Business Days prior to filing with the SEC, as the case may be, or (b) the Company shall not have given due consideration to any comments thereon received from the Investor or its counsel, unless the Company
reasonably has determined that it is necessary to amend the Registration Statement or make any supplement to the Prospectus to comply with the Securities Act or any other applicable law or regulation, in which case the Company shall promptly (but in
no event later than two (2) Business Days) so inform the Investor, the Investor shall be provided with a reasonable opportunity to review and comment upon any disclosure referring to the Investor, the Transaction Documents or the transactions
contemplated thereby, as applicable, and the Company shall expeditiously furnish to the Investor a copy thereof. In addition, for so long as, in the reasonable opinion of counsel for the Investor, the Prospectus is required to be delivered in
connection with any acquisition or sale of Securities by the Investor, the Company shall not file any Prospectus Supplement with respect to the Securities without furnishing to the Investor as many copies of such Prospectus Supplement, together with
the Prospectus, as the Investor may reasonably request. 
 (d) Sufficient Number of Shares Registered. In the event the number of
shares available under the Shelf Registration Statement is insufficient to cover the Registrable Securities, the Company shall, to the extent necessary and permissible, amend the Shelf Registration Statement or file a new registration statement
(together with any prospectuses or prospectus supplements thereunder, a “New Registration Statement”), so as to cover all of such Registrable Securities as soon as reasonably practicable, but in any event not
later than ten (10) Business Days after the necessity therefor arises. The Company shall use its reasonable best efforts to have such amendment or New Registration Statement become effective as soon as reasonably practicable following the
filing thereof. 
 (e) Offering. If the SEC seeks to characterize any offering pursuant to a Registration Statement filed pursuant to
this Agreement as constituting an offering of securities that does not permit such Registration Statement to become effective and be used by the Investor under Rule 415 at then-prevailing market prices (and not fixed prices), or if after the filing
of the Initial Prospectus Supplement with the SEC pursuant to Section 2(a), the Company is otherwise required by the Staff or the SEC to reduce the number of Registrable Securities included in such initial Registration
Statement, then the Company shall reduce the number of Registrable Securities to be included in such initial Registration Statement (with the prior consent, which shall not be unreasonably withheld, of the Investor and its legal counsel as to the
specific Registrable Securities to be removed therefrom) until such time as the SEC shall so permit such Registration Statement to become effective and be used as aforesaid. In the event of any reduction in Registrable Securities pursuant to this
paragraph, the Company shall file one or more New Registration Statements in accordance with Section 2(d) until such time as all Registrable Securities have been included in Registration Statements that have been declared
effective and the prospectuses contained therein is available for use by the Investor. Notwithstanding any provision herein or in the Purchase Agreement to the contrary, the Company’s obligations to register Registrable Securities (and any
related conditions to the Investor’s obligations) shall be qualified as necessary to comport with any requirement of the SEC or the Staff as addressed in this Section 2(e). 

3. RELATED OBLIGATIONS. 

With respect to the Registration Statement and whenever any Registrable Securities are to be Registered pursuant to
Section 2, including on the Shelf Registration Statement or on any New Registration Statement, the Company shall use its reasonable best efforts to effect the registration of the Registrable Securities in accordance with
the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations: 

  
 3 

 (a) Notifications. The Company will notify the Investor promptly of the time when any
subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any
subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information. 

(b) Amendments. The Company will prepare and file with the SEC, promptly upon the Investor’s request, any amendments or supplements
to the Shelf Registration Statement, any New Registration Statement or any Prospectus, as applicable, that, in the reasonable opinion of the Investor and the Company, may be necessary or advisable in connection with any acquisition or sale of
Registrable Securities by the Investor until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of disposition by the Investor thereof as set forth in such Registration Statement. 

(c) Investor Review. The Company will not file any amendment or supplement to the Registration Statement, any New Registration Statement
or any Prospectus, other than documents incorporated by reference, relating to the Investor, the Registrable Securities or the transactions contemplated hereby unless (A) the Investor shall have been advised and afforded the opportunity to
review and comment thereon at least two (2) Business Days prior to filing with the SEC, (B) the Company shall have given due consideration to any comments thereon received from the Investor or its counsel and (C) the Company will
furnish to the Investor at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or any Prospectus, except for those documents available via EDGAR. 

(d) Form S-3. The Company will cause each amendment or supplement to the Prospectus, other than
documents incorporated by reference, to be filed with the SEC as required pursuant to the rules of Form S-3. 

(e) Copies Available. The Company will furnish to the Investor and its counsel (at the expense of the Company) copies of the
Registration Statement, the Prospectus (including all documents incorporated by reference therein), any Prospectus Supplement, any New Registration Statement and all amendments and supplements to the Registration Statement, the Prospectus or any New
Registration Statement that are filed with the SEC during the Registration Period (including all documents filed with or furnished to the SEC during such period that are deemed to be incorporated by reference therein), in each case as soon as
reasonably practicable and in such quantities as the Investor may from time to time reasonably request and, at the Investor’s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Registrable
Securities may be made; provided, however, that the Company shall not be required to furnish any document (other than the Prospectus) to the Investor to the extent such document is available on EDGAR. 

(f) Qualification. The Company shall will cooperate with the Investor in endeavoring to qualify the Registrable Securities for sale and
resale under thetake all such action, if any, as is reasonably necessary in order to obtain an exemption for or to qualify (i) the issuance of the Commitment Shares and the sale of the Purchase Shares to the Investor under this Agreement and
(ii) any subsequent resale of all Commitment Shares and all Purchase Shares by the Investor, in each case, under applicable securities or “Blue Sky” laws of the states of the United States in such states as is reasonably requested by
the Investor during the Registration Period, and shall provide evidence of any such action so taken to the Investor. During the Registration Period, the Company shall promptly notify the Investor of the receipt by the Company of any notification
with respect to the suspension of the registration or qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction in the United States or its receipt of actual notice of the
initiation or threat of any proceeding for such purpose. 

  
 4 

 (g) Notification of Stop Orders; Material Changes. The Company shall advise the
Investor promptly (but in no event later than 24 hours) and shall confirm such advice in writing, in each case: (i) of the Company’s receipt of notice of any request by the SEC or any other federal or state governmental authority for
amendment of or a supplement to the Registration Statement or any Prospectus or for any additional information; (ii) of the Company’s receipt of notice of the issuance by the SEC or any other federal or state governmental authority of any
stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending the use of the Prospectus or Prospectus Supplement, or any New Registration Statement, or of the Company’s receipt of any notification of the
suspension of qualification of the Registrable Securities for offering or sale in any jurisdiction or the initiation or contemplated initiation of any proceeding for such purpose; and (iii) of the Company becoming aware of the happening of any
event, which makes any statement of a material fact made in the Registration Statement or any Prospectus untrue or which requires the making of any additions to or changes to the statements then made in the Registration Statement or any Prospectus
in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case of any Prospectus, in light of the circumstances under which they were made) not
misleading, or of the necessity to amend the Registration Statement or any Prospectus to comply with the Securities Act or any other law. The Company shall not be required to disclose to the Investor the substance or specific reasons of any of the
events set forth in clauses (i) through (iii) of the immediately preceding sentence, but rather, shall only be required to disclose that the event has occurred. If at any time the SEC, or any other federal or state governmental authority shall
issue any stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending the use of the Prospectus or Prospectus Supplement, the Company shall use its reasonable best efforts to obtain the withdrawal of such order
at the earliest possible time. The Company shall furnish to the Investor, without charge, a copy of any correspondence from the SEC or the staff of the SEC, or any other federal or state governmental authority to the Company or its representatives
relating to the Shelf Registration Statement, any New Registration Statement or any Prospectus, or Prospectus Supplement as the case may be. The Company shall not deliver to the Investor any Regular Purchase Notice, Accelerated Purchase Notice or
Additional Accelerated Purchase Notice, and the Investor shall not be obligated to purchase any shares of Common Stock under this Agreement, during the continuation or pendency of any of the foregoing events. If at any time the SEC shall issue any
stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending the use of the Prospectus or any Prospectus Supplement, the Company shall use its reasonable best efforts to obtain the withdrawal of such order at
the earliest possible time. The Company shall furnish to the Investor, without charge, a copy of any correspondence from the SEC or the staff of the SEC to the Company or its representatives relating to the Registration Statement or the Prospectus,
as the case may be. 
 (h) Listing on the Principal Market. The Company shall promptly secure the listing, or conditional listing as
applicable, of all of the Purchase Shares and Commitment Shares to be issued to the Investor hereunder on the Principal Market (subject to standard listing conditions, if any, for transactions of this nature, official notice of issuance and the
Exchange Cap) and upon each other national securities exchange or automated quotation system, if any, upon which the Common Stock are then listed, and shall use its reasonable best efforts to maintain, so long as any Common Stock shall be so listed,
such listing of all such Registrable Securities from time to time issuable hereunder. The Company shall use its reasonable best efforts to maintain the listing of the Common Stock on the Principal Market and shall comply in all respects with the
Company’s reporting, filing and other obligations under the bylaws or rules and regulations of the Principal Market. Neither the Company nor any of its Subsidiaries shall take any action that would reasonably be expected to result in the
delisting or suspension of the Common Stock on the Principal Market. The Company shall promptly, and in no event later than the following Business Day, provide to the Investor copies of any notices it receives from any Person regarding the continued
eligibility 

  
 5 

 
of the Common Stock for listing on the Principal Market; provided, however, that the Company shall not provide the Investor copies of any such notice that the Company reasonably
believes constitutes material non-public information and the Company would not be required to publicly disclose such notice in any report or statement filed with the SEC and under the Exchange Act (including
on Form 8-K) or the Securities Act. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 3(h). 

(i) Delivery of Shares. The Company shall cooperate with the Investor to facilitate the timely preparation and delivery of DWAC Shares
(not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to the Shelf Registration Statement or any New Registration Statement and enable such DWAC Shares to be in such denominations or amounts as the
Investor may reasonably request and registered in such names as the Investor may request. 
 (j) Transfer Agent. The Company shall at
all times maintain the services of the Transfer Agent with respect to its Common Stock. 
 (k) Approvals. The Company shall use its
reasonable best efforts to cause the Registrable Securities covered by any Registration Statement to be Registered with or approved by such other governmental agencies or authorities in the United States as may be necessary to consummate the
disposition of such Registrable Securities. 
 (l) Confirmation of Effectiveness. If reasonably requested by the Investor at any time,
the Company shall deliver to the Investor a written confirmation from the Company’s counsel of whether or not the effectiveness of such Registration Statement has lapsed at any time for any reason (including, without limitation, the issuance of
a stop order) and whether or not the Registration Statement is currently effective and available to the Company for sale of all of the Registrable Securities. 

(m) Further Assurances. The Company agrees to take all other reasonable actions as necessary and reasonably requested by the Investor to
expedite and facilitate disposition by the Investor of Registrable Securities pursuant to any Registration Statement. 
 (n) Suspension of
Sales. The Investor agrees that, upon receipt of any notice from the Company of the existence of any suspension or stop order as set forth in Sections 3(f) or 3(g), the Investor will immediately discontinue disposition of
Registrable Securities pursuant to any Registration Statement covering such Registrable Securities until the Investor’s receipt of the copies of a notice regarding the resolution or withdrawal of the suspension or stop order as contemplated by
Section 3(f) or 3(g). Notwithstanding anything to the contrary, the Company shall cause its transfer agent to promptly deliver to the Investor DWAC Shares of Common Stock without any restrictive legend in accordance
with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to which the Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company of the happening
of any event of the kind described in Section 3(f) or 3(g) and for which the Investor has not yet settled. 

4. OBLIGATIONS OF THE INVESTOR. 

(a) Investor Information. The Investor has furnished to the Company in Exhibit A hereto such information regarding itself, the
Registrable Securities held by it, the Registrable Securities held by it and the intended method of disposition thereof, including any arrangement between the Investor and any other Person relating to the sale or distribution of the Securities, as
required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request. The Company shall notify the Investor in writing of any other information
the Company reasonably requires from the Investor in connection with any Registration Statement hereunder. The Investor will as promptly as practicable notify the Company of any material change in the information set forth in Exhibit A, other
than changes in its ownership of Common Stock. 

  
 6 

 (b) Investor Cooperation. The Investor agrees to cooperate with the Company as
reasonably requested by the Company in connection with the preparation and filing of any amendments and supplements to any Registration Statement or New Registration Statement hereunder. 

5. EXPENSES OF REGISTRATION. 

All reasonable expenses of the Company, other than sales or brokerage commissions and fees and disbursements of counsel for the Investor,
incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and
disbursements of counsel for the Company, shall be paid by the Company. 
 6. INDEMNIFICATION. 

(a) To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each Person,
if any, who controls the Investor, the members, the directors, officers, partners, employees, members, managers, agents, representatives of the Investor and each Person, if any, who controls the Investor within the meaning of the Securities Act or
the Exchange Act (each, an “Indemnified Person”), against any losses, claims, damages, liabilities, judgments, fines, penalties, charges, costs, reasonable attorneys’ fees, amounts paid in settlement (with the consent of the
Company, such consent not to be unreasonably withheld) or reasonable expenses, (collectively, “Claims”) reasonably incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or
appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency or body or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto
(“Indemnified Damages”), to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement
or alleged untrue statement of a material fact in the Shelf Registration Statement, any New Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the
securities or other “blue sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”), or the omission or alleged omission to state a material fact required to be stated therein or
necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained in the final Prospectus or the omission or alleged omission to state therein any material fact necessary
to make the statements made therein, in light of the circumstances under which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any other law,
including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities pursuant to the Shelf Registration Statement or any New Registration Statement or (iv) any
material violation by the Company of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, “Violations”). The Company shall reimburse each Indemnified Person promptly as such expenses are
incurred and are due and payable, for any reasonable out-of-pocket legal fees or other reasonable expenses incurred by them in connection with investigating or defending
any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a): (A) shall not apply to a Claim by an Indemnified Person arising out of or based upon a
Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by the Investor or such Indemnified Person expressly for use in connection with the preparation of the Registration Statement, any New
Registration Statement, the Prospectus or any such amendment 

  
 7 

 
thereof or supplement thereto, if such in each case if the foregoing was timely made available by the Company; (B) with respect to any superseded prospectus, shall not inure to the benefit
of any such Person from whom the Person asserting any such Claim purchased the Registrable Securities that are the subject thereof (or to the benefit of any other Indemnified Person) if the untrue statement or omission of material fact contained in
the superseded prospectus was corrected in the revised prospectus, as then amended or supplemented, if such revised prospectus was timely made available by the Company pursuant to Section 3(c) or
Section 3(e), and the Indemnified Person was promptly advised in writing not to use the incorrect prospectus prior to the use giving rise to a violation; (C) shall not be available to the extent such Claim is based on
a failure of the Investor to deliver, or to cause to be delivered, the prospectus made available by the Company, if such prospectus was theretofore made available by the Company pursuant to Section 3(c) or
Section 3(e); and (D) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to
Section 8. 
 (b) In connection with the Shelf Registration Statement, any New Registration Statement or
Prospectus, the Investor agrees to indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers who signed
the Shelf Registration Statement or signs any New Registration Statement, each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act (collectively and together with an Indemnified Person, an
“Indemnified Party”), against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based
upon any Violation, in each case to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with written information about the Investor set forth on Exhibit A attached hereto or updated from time to
time in writing by the Investor and furnished to the Company by the Investor expressly for inclusion in the Shelf Registration Statement or Prospectus or any New Registration Statement or from the failure of the Investor to deliver or to cause to be
delivered the prospectus made available by the Company, if such prospectus was timely made available by the Company pursuant to Section 3(c) or Section 3(e); and, subject to
Section 6(d), the Investor will reimburse any reasonable out-of-pocket legal or other expenses reasonably incurred by them in connection with
investigating or defending any such Claim; provided, however, that the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in
Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Investor, which consent shall not be unreasonably withheld; provided,
further, however, that the Investor shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to the Investor as a result of the sale of
Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of the Registrable
Securities by the Investor pursuant to Section 8. 
 (c) Promptly after receipt by an Indemnified Person or
Indemnified Party under this Section 6 of notice of the commencement of any action or proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if a
Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the
Indemnified Person or the Indemnified Party, as the case may be; provided, however, that an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with the fees and expenses to be paid by the
indemnifying party, if, in the reasonable opinion of counsel retained by the 

  
 8 

 
indemnifying party, the representation by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential differing
interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such proceeding. The Indemnified Party or Indemnified Person shall cooperate with the indemnifying party in connection with any
negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or claim. The
indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action,
claim or proceeding effected without its written consent, provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the consent of the
Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or
Indemnified Person of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person
with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action
shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this Section 6, except to the extent that the indemnifying party is prejudiced in its ability to defend such action. 

(d) The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during
the course of the investigation or defense, as and when bills are received or Indemnified Damages are incurred. Any Person receiving a payment pursuant to this Section 6 that is later determined not to be entitled to such
payment shall return such payment to the person making it. 
 (e) The indemnity agreements contained herein shall be in addition to
(i) any cause of action or similar right of the Indemnified Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law. 

7. CONTRIBUTION. 
 To the
extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect to any amounts for which it would otherwise be liable under
Section 6 to the fullest extent permitted by law; provided, however, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and (ii) contribution by any seller of Registrable Securities shall be limited in amount to the net
amount of proceeds received by such seller from the sale of such Registrable Securities. 
 8. ASSIGNMENT OF REGISTRATION RIGHTS.

 The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor;
provided, however, that any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company remains the surviving entity immediately after such transaction shall not be deemed
an assignment. The Investor may not assign its rights under this Agreement without the prior written consent of the Company, other than to an affiliate of the Investor controlled by Jonathan Cope or Josh Scheinfeld, in which case the assignee must
agree in writing to be bound by the terms and conditions of this Agreement. 

  
 9 

 9. AMENDMENT OF REGISTRATION RIGHTS. 

No provision of this Agreement may be amended or waived by the parties from and after the date that is one Business Day immediately preceding
the initial filing of the Initial Prospectus Supplement with the SEC. Subject to the immediately preceding sentence, no provision of this Agreement may be (i) amended other than by a written instrument signed by both parties hereto or
(ii) waived other than in a written instrument signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such
right or remedy, shall not operate as a waiver thereof. 
 10. MISCELLANEOUS. 

(a) Notices. Any notices, consents or other communications required or permitted to be given under the terms of this Agreement must be
in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on
file by the sending party); (iii) upon receipt, when sent by electronic message (provided the recipient responds to the message and confirmation of both electronic messages are kept on file by the sending party); or (iv) one (1) Business Day
after timely deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications shall be: 

If to the Company: 

Unum Therapeutics Inc. 

200 Cambridge Park Drive, Suite 3100 

Cambridge, MA 02140 

Telephone:         617.945.5576 

E-mail:
              matthew.osborne@unumrx.com 

Attention:           Matthew Osborne 

With a copy to (which shall not constitute notice or service of process): 

Goodwin Procter LLP 

100 Northern Avenue 

Boston, Massachusetts 02210 

Telephone:       617.570.1955 

E-mail:             
DLauzon@goodwinlaw.com 
 Attention:         Danielle M. Lauzon, Esq. 

If to the Investor: 

Lincoln Park Capital Fund, LLC 

440 North Wells, Suite 410 

Chicago, IL 60654 

Telephone:       312.822.9300 

Facsimile:        312.822.9301 

E-mail:
            jscheinfeld@lpcfunds.com/jcope@lpcfunds.com 

Attention:         Josh Scheinfeld/Jonathan Cope 

  
 10 

 With a copy to (which shall not constitute notice or service of process):

 K&L Gates, LLP 

200 S. Biscayne Blvd., Ste. 3900 

Miami, Florida 33131 

Telephone:        305.539.3306 

Facsimile:         305.358.7095 

E-mail:              
clayton.parker@klgates.com 
 Attention:          Clayton E. Parker, Esq.

 If to the Transfer Agent: 

Computershare 

Meidinger Tower, 462 South 4th Street 

Louisville, KY 40202 

Telephone:       502.301.6105

E-mail:
            Patricia.Peachey@computershare.com 
 Attention:
        Patti Peachey 
 or at such other address, e-mail address and/or
facsimile number and/or to the attention of such other person as the recipient party has specified by written notice given to each other party at least one (1) Business Day prior to the effectiveness of such change. Written confirmation of
receipt (A) given by the recipient of such notice, consent or other communication, (B) mechanically or electronically generated by the sender’s facsimile machine containing the time, date, and recipient facsimile number,
(C) electronically generated by the sender’s electronic mail containing the time, date and recipient email address or (D) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of receipt in
accordance with clause (i), (ii), (iii) or (iv) above, respectively. Any party to this Agreement may give any notice or other communication hereunder using any other means (including messenger service, ordinary mail or electronic mail), but no
such notice or other communication shall be deemed to have been duly given unless it actually is received by the party for whom it is intended. 

(b) No Waiver. No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor
shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege. 

(c) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement and the other
Transaction Documents shall be governed by the internal laws of the State of Illinois, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Illinois or any other jurisdictions) that would cause the
application of the laws of any jurisdictions other than the State of Illinois. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the State of Illinois, County of Cook, for the adjudication
of any dispute hereunder or under the other Transaction Documents or in connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or
proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be 

  
 11 

 
deemed to limit in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 

(d) Integration. This Agreement, the Purchase Agreement and the other Transaction Documents constitute the entire understanding
among the parties hereto with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein. This Agreement, the Purchase
Agreement and the other Transaction Documents supersede all other prior oral or written agreements between the Investor, the Company, their affiliates and persons acting on their behalf with respect to the subject matter hereof and thereof.

 (e) Successors and Assigns. Subject to the requirements of Section 8, this Agreement shall inure to the
benefit of and be binding upon the permitted successors and assigns of each of the parties hereto. 
 (f) Headings. The headings in
this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement. 
 (g)
Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the
other party; provided that a facsimile or pdf (or other electronic reproduction of a) signature shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original,
not a facsimile or pdf (or other electronic reproduction of a) signature. 
 (h) Further Assurances. Each party shall do and perform,
or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents as the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby. 
 (i) No Strict Construction.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of strict construction will be applied against any party. 

(j) No Third-Party Benefits This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 
 (k) Termination. The
obligations of the Company contained in Sections 2, 3, 5 and 8 of this Agreement shall terminate in their entirety upon the expiration of the Registration Period. 

*     *     *     *     *     * 

  
 12 

 IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be
duly executed as of day and year first above written. 
  

			
	THE COMPANY:
	
	UNUM THERAPEUTICS INC.
		
	By:	 	 /s/ Charles Wilson

	Name: Charles Wilson
	Title:   President and CEO
	
	INVESTOR:
	
	LINCOLN PARK CAPITAL FUND, LLC
	BY: LINCOLN PARK CAPITAL, LLC
	BY: ALEX NOAH INVESTORS, INC.
		
	By:	 	 /s/ Jonathan Cope

	Name: Jonathan Cope
	Title:   President

  
 13 

 EXHIBIT A 

Information About The Investor Furnished To The Company By The Investor 

Expressly For Use In Connection With The Registration Statement and Prospectus 

Information With Respect to Lincoln Park Capital 

Immediately prior to the date of the Purchase Agreement, Lincoln Park Capital Fund, LLC, beneficially owned 0 shares of Common Stock. Josh
Scheinfeld and Jonathan Cope, the Managing Members of Lincoln Park Capital, LLC, the manager of Lincoln Park Capital Fund, LLC, are deemed to be beneficial owners of all of the Common Stock owned by Lincoln Park Capital Fund, LLC. Messrs. Cope and
Scheinfeld have shared voting and investment power over the shares being offered under the prospectus supplement filed with the SEC in connection with the transactions contemplated under the Purchase Agreement. Lincoln Park Capital, LLC is not a
licensed broker dealer or an affiliate of a licensed broker dealer.EX-4.2

 Exhibit 4.2 
  

 
  

ZIMMER BIOMET HOLDINGS, INC. 

$600,000,000 3.050% Notes due 2026 

$900,000,000 3.550% Notes due 2030 

SEVENTH SUPPLEMENTAL INDENTURE 

Dated as of March 20, 2020 

to 
 Indenture dated as of
November 17, 2009 
 WELLS FARGO BANK, NATIONAL ASSOCIATION 

Trustee 
  

 
  

 Table of Contents 

 

							
	 	 	 	  	Page	 
	 ARTICLE I
	  

	
	 DEFINITIONS AND INCORPORATION BY
REFERENCE
	  

			
	 SECTION 1.01.
	 	Application of this Seventh Supplemental Indenture	  	 	1	 
	 SECTION 1.02.
	 	Definitions	  	 	2	 
	 SECTION 1.03.
	 	Incorporation by Reference of Trust Indenture Act	  	 	5	 
	
	 ARTICLE II
	  

	
	 CREATION, FORMS,
	  

	 TERMS AND CONDITIONS OF THE SECURITIES
	  

			
	 SECTION 2.01.
	 	Creation of the Notes	  	 	6	 
	 SECTION 2.02.
	 	Form of the Notes	  	 	6	 
	 SECTION 2.03.
	 	Terms and Conditions of the 2026 Notes	  	 	6	 
	 SECTION 2.04.
	 	Terms and Conditions of the 2030 Notes	  	 	7	 
	 SECTION 2.05.
	 	Ranking	  	 	9	 
	 SECTION 2.06.
	 	Sinking Fund	  	 	9	 
	
	 ARTICLE III
	  

	
	 REDEMPTION
	  

			
	 SECTION 3.01.
	 	Optional Redemption	  	 	9	 
	 SECTION 3.02.
	 	General	  	 	9	 
	
	 ARTICLE IV
	  

	
	 CHANGE OF CONTROL
	  

			
	 SECTION 4.01.
	 	Repurchase at the Option of Holders Upon a Change of Control Repurchase Event	  	 	10	 
	
	 ARTICLE V
	  

	
	 TRANSFER AND EXCHANGE
	  

			
	 SECTION 5.01.
	 	Transfer and Exchange	  	 	11	 

  
 ii 

							
	
	ARTICLE VI	  

	
	TRUSTEE	  

			
	 SECTION 6.01.
	 	Corporate Trust Office	  	 	13	 
	 SECTION 6.02.
	 	Recitals of Fact; Certain Other Matters	  	 	13	 
	 SECTION 6.03.
	 	Successor	  	 	13	 
	
	ARTICLE VII	  

	
	MISCELLANEOUS PROVISIONS	  

			
	 SECTION 7.01.
	 	Ratification of Original Indenture	  	 	13	 
	 SECTION 7.02.
	 	Effect of Headings	  	 	14	 
	 SECTION 7.03.
	 	Successors and Assigns	  	 	14	 
	 SECTION 7.04.
	 	Separability Clause	  	 	14	 
	 SECTION 7.05.
	 	Governing Law	  	 	14	 
	 SECTION 7.06.
	 	Counterparts	  	 	14	 

 EXHIBITS 
  

			
	 EXHIBIT A
 EXHIBIT B
	  	 Form of Global 2026 Note
 Form of Global 2030
Note

  
 iii 

 SEVENTH SUPPLEMENTAL INDENTURE, dated as of March 20, 2020
(this “Seventh Supplemental Indenture”), between ZIMMER BIOMET HOLDINGS, INC. (f/k/a ZIMMER HOLDINGS, INC.), a corporation duly organized and existing under the laws of the State of Delaware (herein called the “Company”), having
its principal offices at 345 East Main Street, Warsaw, Indiana, and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”). 

RECITALS 
 WHEREAS,
the Company executed and delivered to the Trustee an Indenture, dated as of November 17, 2009 (the “Original Indenture”), providing for the issuance by the Company from time to time of debt securities evidencing unsecured and
unsubordinated indebtedness of the Company to be issued in one or more series; 
 WHEREAS, the Original Indenture provides, among
other things, that by means of a supplemental indenture, the Company and the Trustee may, without the consent of Holders, create one or more series of the Company’s debt securities and establish the form and terms and conditions thereof; 

WHEREAS, the Company intends by this Seventh Supplemental Indenture to create and provide for the issuance of two new series of debt
securities to be designated as the “3.050% Notes due 2026” (the “2026 Notes”) and the “3.550% Notes due 2030” (the “2030 Notes” and, together with the 2026 Notes, the “Notes”); 

WHEREAS, the Board of Directors of the Company has authorized the execution and delivery of the Seventh Supplemental Indenture, the
issuance of the Notes and the forms, terms and conditions of the Notes pursuant to Sections 201, 301 and 901 of the Original Indenture; and 

WHEREAS, all acts and things necessary to make the Notes, when the Notes have been executed by the Company, authenticated by the
Trustee, issued upon the terms and subject to the conditions set forth hereinafter and in the Original Indenture and delivered as provided in the Indenture against payment therefor, valid, binding and legal obligations of the Company, enforceable
against the Company according to their terms, and all actions required to be taken by the Company under the Original Indenture to make this Seventh Supplemental Indenture a valid, binding and legal agreement of the Company, have been done; 

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the sufficiency and adequacy of which
are hereby acknowledged, the parties hereto hereby agree as follows: 
 ARTICLE I 

DEFINITIONS AND INCORPORATION BY REFERENCE 

SECTION 1.01. Application of this Seventh Supplemental Indenture. Notwithstanding any other provision of this Seventh Supplemental
Indenture, the provisions of this Seventh 

 
Supplemental Indenture, including the covenants set forth herein, are expressly and solely for the benefit of the Notes. The Notes constitute two separate series of notes as provided in
Section 301 of the Original Indenture. 
 SECTION 1.02. Definitions. Capitalized terms used in this Seventh Supplemental
Indenture and not otherwise defined herein shall have the meanings ascribed to them in the Original Indenture. In addition, the following terms shall have the following meanings to be equally applicable to both the singular and the plural forms of
the terms defined: 
 “2026 Interest Payment Date” has the meaning set forth in Section 2.03(c). 

“2026 Maturity Date” has the meaning set forth in Section 2.03(b). 

“2026 Notes” has the meaning set forth in the Recitals hereto. 

“2026 Regular Record Date” has the meaning set forth in Section 2.03(c). 

“2030 Interest Payment Date” has the meaning set forth in Section 2.04(c). 

“2030 Maturity Date” has the meaning set forth in Section 2.04(b). 

“2030 Notes” has the meaning set forth in the Recitals hereto. 

“2030 Regular Record Date” has the meaning set forth in Section 2.04(c). 

“Below Investment Grade Rating Event” means, with respect to either series of Notes, the Notes of such series
are rated below Investment Grade by each of the Rating Agencies on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the 60-day period
following public notice of the occurrence of a Change of Control (which period shall be extended so long as the rating of the Notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
provided that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below
Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Company that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall
have occurred at the time of the Below Investment Grade Rating Event). The Trustee shall not be responsible for monitoring the Company’s rating status, making any request upon any Rating Agency, or determining whether any Below Investment Grade
Rating Event with respect to either series of Notes has occurred. 
 “Business Day” means each Monday, Tuesday, Wednesday,
Thursday and Friday that is neither a legal holiday nor a day on which the Trustee or banking institutions in New York, New York are authorized or required by law or regulation to close. 

  
 2 

 “Change of Control” means the occurrence of any of the following: 

(1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in
one or a series of related transactions, of all or substantially all of the properties or assets of the Company and its subsidiaries taken as a whole to any “person” (as that term is used in Section 13(d)(3) of the Exchange Act),
other than the Company or one of its subsidiaries; 
 (2) the adoption of a plan relating to the Company’s liquidation
or dissolution; or 
 (3) the consummation of any transaction or series of related transactions (including, without
limitation, any merger or consolidation) the result of which is that any “person” (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one or more of its wholly-owned subsidiaries, becomes the
beneficial owner, directly or indirectly, of more than 50% of the then outstanding number of shares of the Company’s Voting Stock. 

“Change of Control Repurchase Event” means, with respect to either series of Notes, the occurrence of both a Change of
Control and a Below Investment Grade Rating Event with respect to such series of Notes. 
 “Company” has the meaning set
forth in the Recitals hereto. 
 “Comparable Treasury Issue” means the United States Treasury security selected by the
Quotation Agent as having a maturity comparable to the remaining term of the series of Notes to be redeemed (assuming, for this purpose, such Notes mature on the applicable Par Call Date) that would be utilized, at the time of selection and in
accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes. 

“Comparable Treasury Price” means, with respect to any Redemption Date, (1) the average of four Reference Treasury
Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, (2) if the Company can only obtain less than four such Reference Treasury Dealer Quotations, the average of all such
quotations or (3) if the Company can only obtain one Reference Treasury Dealer Quotation, such quotation. 
 “Corporate Trust
Office” shall be the office of the Trustee at which the Indenture shall be principally administered, which at the date of this Seventh Supplemental Indenture is 150 East 42nd Street, 40th Floor, New York, New York 10017, Attn: Corporate
Trust Services, or such other address as to which the Trustee may give notice to the Company. 
 “Dollar” and
“$” means the lawful currency of the United States of America. 
 “DTC” means The Depository Trust
Company, its nominees and their successors and assigns. 

  
 3 

 “Exchange Act” means the Securities Exchange Act of 1934, as amended from
time to time. 
 “Global Note” means a single permanent fully-registered global note in book-entry form, without coupons,
substantially in the form of Exhibit A or Exhibit B attached hereto, as applicable. 
 “Indenture” means the Original
Indenture as supplemented by this Seventh Supplemental Indenture. 
 “Investment Grade” means a rating of Baa3 or better by
Moody’s (or its equivalent under any successor rating categories of Moody’s) and a rating of BBB- or better by S&P (or its equivalent under any successor rating categories of S&P) or the
equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by the Company. 

“Moody’s” means Moody’s Investors Service, Inc. and any successor to its rating agency business. 

“Notes” has the meaning set forth in the Recitals hereto. 

“Original Indenture” has the meaning set forth in the Recitals hereto. 

“Par Call Date” means (a) in the case of the 2026 Notes, December 15, 2025, and (b) in the case of the 2030
Notes, December 20, 2029. 
 “Paying Agent Office” means the designated office of the Trustee of which the corporate
trust paying agent office of the Trustee shall, at any particular time be administered, which at the date of this Seventh Supplemental Indenture is Corporate Trust Operations, MAC N9300-070, 600 South Fourth
Street, Seventh Floor, Minneapolis, MN 55415, or such other address as to which the Trustee may give notice to the Company. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Company. 

“Rating Agency” means (1) each of Moody’s and S&P; and (2) if either of Moody’s or S&P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company’s control, a “nationally recognized statistical rating organization” within the meaning of Rule
15c3-1(c)(2)(vi)(F) under the Exchange Act, selected by the Company as a replacement agency for Moody’s or S&P, as the case may be. 

“Redemption Date” means the Business Day on which Notes are redeemed by the Company pursuant to Article III hereof. 

“Reference Treasury Dealer” means (1) each of BofA Securities, Inc., Citigroup Global Markets Inc., RBC Capital Markets,
LLC and Wells Fargo Securities, LLC; provided, however, that if any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York, New York (a “Primary Treasury Dealer”), the Company will substitute therefor
another Primary Treasury Dealer, and (2) any other Primary Treasury Dealer selected by the Company. 

  
 4 

 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any Redemption Date, the average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the
Company by such Reference Treasury Dealer at 5:00 p.m., New York, New York time, on the third Business Day preceding such Redemption Date. 

“Registered Securities” means any Securities which are registered in the Security Register. 

“Remaining Scheduled Payments” means, with respect to each Note to be redeemed, the remaining scheduled payments of principal
and interest thereon that would be due after the related Redemption Date for such redemption (not including any portion of such payments of interest accrued as of the Redemption Date) and assuming, for this purpose, that such Note matures on the
applicable Par Call Date. 
 “S&P” means S&P Global Ratings, a division of S&P Global Inc., and any successor
to its rating agency business. 
 “Treasury Rate” means, with respect to any Redemption Date, the rate per annum equal to
the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such Redemption Date.

 “Trustee” has the meaning set forth in the Recitals hereto. 

“Voting Stock” means, with respect to any Person, capital stock of any class or kind the holders of which are ordinarily, in
the absence of contingencies, entitled to vote for the election of directors (or Persons performing similar functions) of such Person, even if the right to so vote has been suspended by the happening of such a contingency. 

SECTION 1.03. Incorporation by Reference of Trust Indenture Act. The Indenture is subject to the mandatory provisions of the Trust
Indenture Act, which are incorporated by reference in and made a part of the Indenture. The following Trust Indenture Act terms have the following meanings: 

“indenture securities” means the Notes. 

“indenture security holder” means a Holder. 

“indenture to be qualified” means this Seventh Supplemental Indenture. 

“indenture trustee” or “institutional trustee” means the Trustee. 

“obligor” on the indenture securities means the Company and any other obligor on the indenture securities. 

  
 5 

 All other Trust Indenture Act terms used in this Indenture that are defined by the Trust
Indenture Act, defined by Trust Indenture Act reference to another statute or defined by Securities and Exchange Commission rule have the meanings assigned to them by such definitions. 

ARTICLE II 
 CREATION,
FORMS, 
 TERMS AND CONDITIONS OF THE SECURITIES 

SECTION 2.01. Creation of the Notes. In accordance with Section 301 of the Original Indenture, the Company hereby creates each of
the 2026 Notes and the 2030 Notes as a separate series of its securities issued pursuant to the Indenture. The 2026 Notes shall be issued initially in an aggregate principal amount of $600,000,000 and the 2030 Notes shall be issued initially in an
aggregate principal amount of $900,000,000, except as permitted by Sections 304, 305 or 306 of the Original Indenture. 
 SECTION 2.02.
Form of the Notes. The Notes shall each be issued in the form of Global Notes, duly executed by the Company and authenticated by the Trustee, which shall be deposited with the Trustee as custodian for DTC and registered in the name of
“Cede & Co.,” as the nominee of DTC. The 2026 Notes shall be substantially in the form of Exhibit A attached hereto and the 2030 Notes shall be substantially in the form of Exhibit B attached hereto. So long as DTC, or its
nominee, is the registered owner of a Global Note, DTC or its nominee, as the case may be, shall be considered the sole owner or Holder of the Notes represented by such Global Note for all purposes under the Indenture. Ownership of beneficial
interests in such Global Note shall be shown on, and transfers thereof will be effected only through, records maintained by DTC (with respect to beneficial interests of participants) or by participants or Persons that hold interests through
participants (with respect to beneficial interests of beneficial owners). 
 SECTION 2.03. Terms and Conditions of the 2026 Notes.
The 2026 Notes shall be governed by all the terms and conditions of the Original Indenture, as supplemented by this Seventh Supplemental Indenture. In particular, the following provisions shall be terms of the 2026 Notes: 

(a) Title and Aggregate Principal Amount. The title of the 2026 Notes shall be as specified in the Recitals; and the aggregate principal
amount of the 2026 Notes shall be as specified in Section 2.01 of this Article II, except as permitted by Sections 304, 305 or 306 of the Original Indenture. 

(b) Stated Maturity. The 2026 Notes shall mature, and the unpaid principal thereon shall be payable, on January 15, 2026 (the
“2026 Maturity Date”), subject to the provisions of the Original Indenture and Articles III and IV below. 
 (c) Interest.
The rate per annum at which interest shall be payable on the 2026 Notes shall be 3.050%. Interest on the 2026 Notes shall be payable semi-annually in arrears on each January 15 and July 15, commencing on July 15, 2020 (each, a
“2026 Interest Payment Date”), to the Persons in whose names the applicable 2026 Notes are registered in the Security 

  
 6 

 
Register applicable to the 2026 Notes at the close of business on the immediately preceding January 1 or July 1, respectively, prior to the applicable 2026 Interest Payment Date
regardless of whether such day is a Business Day (each, a “2026 Regular Record Date”). Interest on the 2026 Notes shall be computed on the basis of a 360-day year consisting of twelve 30-day months. Interest on the 2026 Notes shall accrue from and including March 20, 2020. If a 2026 Interest Payment Date, the 2026 Maturity Date or any earlier Redemption Date with respect to the 2026 Notes
falls on a day that is not a Business Day, the related payment will be made on the next Business Day as if it were made on the date the payment was due, and no interest will accrue on the amount so payable for the period from and after that 2026
Interest Payment Date, the 2026 Maturity Date or any such earlier Redemption Date, as the case may be, to the date the payment is made. Interest payments will include accrued interest from and including the date of original issuance or from and
including the last date in respect to which interest has been paid, as the case may be, to, but excluding, the 2026 Interest Payment Date or the 2026 Maturity Date, as the case may be. 

(d) Registration and Form. The 2026 Notes shall be issuable as Registered Securities as provided in Section 2.02 of this Article
II. The 2026 Notes shall be issued and may be transferred only in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. All payments of principal, redemption price and accrued unpaid interest in respect of the 2026
Notes shall be made by the Company in immediately available funds. 
 (e) Defeasance and Covenant Defeasance. The provisions for
defeasance in Section 1302 of the Original Indenture, and the provisions for covenant defeasance in Section 1303 of the Original Indenture, shall be applicable to the 2026 Notes. 

(f) Further Issues. Notwithstanding anything to the contrary contained in this Seventh Supplemental Indenture or the Original Indenture
(but subject to the terms of this Section 2.03(f)), the Company may, from time to time, without the consent of or notice to the Holders, create and issue further securities having the same ranking and terms and conditions as the 2026 Notes in
all respects, except for the issue date and, in some cases, the public offering price and the first interest payment date. Additional 2026 Notes issued in this manner shall be consolidated with and shall form a single series with the previously
issued 2026 Notes; provided that if such additional 2026 Notes are not fungible with the previously issued 2026 Notes for U.S. federal income tax purposes, such additional 2026 Notes will have a separate CUSIP number. Notice of any issuance
of additional 2026 Notes shall be given to the Trustee and a new supplemental indenture shall be executed in connection therewith. No such additional 2026 Notes may be issued if an Event of Default has occurred and is continuing with respect to the
2026 Notes. 
 (g) Other Terms and Conditions. The 2026 Notes shall have such other terms and conditions as provided in the form
thereof attached as Exhibit A. 
 SECTION 2.04. Terms and Conditions of the 2030 Notes. The 2030 Notes shall be governed by all the
terms and conditions of the Original Indenture, as supplemented by this Seventh Supplemental Indenture. In particular, the following provisions shall be terms of the 2030 Notes: 

  
 7 

 (a) Title and Aggregate Principal Amount. The title of the 2030 Notes shall be as
specified in the Recitals; and the aggregate principal amount of the 2030 Notes shall be as specified in Section 2.01 of this Article II, except as permitted by Sections 304, 305 or 306 of the Original Indenture. 

(b) Stated Maturity. The 2030 Notes shall mature, and the unpaid principal thereon shall be payable, on March 20, 2030 (the
“2030 Maturity Date”), subject to the provisions of the Original Indenture and Articles III and IV below. 
 (c) Interest.
The rate per annum at which interest shall be payable on the 2030 Notes shall be 3.550%. Interest on the 2030 Notes shall be payable semi-annually in arrears on each March 20 and September 20, commencing on September 20, 2020 (each, a
“2030 Interest Payment Date”), to the Persons in whose names the applicable 2030 Notes are registered in the Security Register applicable to the 2030 Notes at the close of business on the immediately preceding March 1 or
September 1, respectively, prior to the applicable 2030 Interest Payment Date regardless of whether such day is a Business Day (each, a “2030 Regular Record Date”). Interest on the 2030 Notes shall be computed on the basis of a 360-day year consisting of twelve 30-day months. Interest on the 2030 Notes shall accrue from and including March 20, 2020. If a 2030 Interest Payment Date, the 2030
Maturity Date or any earlier Redemption Date with respect to the 2030 Notes falls on a day that is not a Business Day, the related payment will be made on the next Business Day as if it were made on the date the payment was due, and no interest will
accrue on the amount so payable for the period from and after that 2030 Interest Payment Date, the 2030 Maturity Date or any such earlier Redemption Date, as the case may be, to the date the payment is made. Interest payments will include accrued
interest from and including the date of original issuance or from and including the last date in respect to which interest has been paid, as the case may be, to, but excluding, the 2030 Interest Payment Date or the 2030 Maturity Date, as the case
may be. 
 (d) Registration and Form. The 2030 Notes shall be issuable as Registered Securities as provided in Section 2.02 of
this Article II. The 2030 Notes shall be issued and may be transferred only in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. All payments of principal, redemption price and accrued unpaid interest in respect of
the 2030 Notes shall be made by the Company in immediately available funds. 
 (e) Defeasance and Covenant Defeasance. The provisions
for defeasance in Section 1302 of the Original Indenture, and the provisions for covenant defeasance in Section 1303 of the Original Indenture, shall be applicable to the 2030 Notes. 

(f) Further Issues. Notwithstanding anything to the contrary contained in this Seventh Supplemental Indenture or the Original Indenture
(but subject to the terms of this Section 2.04(f)), the Company may, from time to time, without the consent of or notice to the Holders, create and issue further securities having the same ranking and terms and conditions as the 2030 Notes in
all respects, except for the issue date and, in some cases, the public offering price and the first interest payment date. Additional 2030 Notes issued in this manner shall be consolidated with and shall form a single series with the previously
issued 2030 Notes; provided that if such additional 2030 Notes are not fungible with the previously issued 2030 Notes for U.S. federal income tax purposes, such additional 2030 Notes will have a separate CUSIP number. Notice of

  
 8 

 
any issuance of additional 2030 Notes shall be given to the Trustee and a new supplemental indenture shall be executed in connection therewith. No such additional 2030 Notes may be issued if an
Event of Default has occurred and is continuing with respect to the 2030 Notes. 
 (g) Other Terms and Conditions. The 2030 Notes
shall have such other terms and conditions as provided in the form thereof attached as Exhibit B. 
 SECTION 2.05. Ranking. The Notes
shall be general unsecured obligations of the Company. The Notes shall rank pari passu in right of payment with all unsecured and unsubordinated indebtedness of the Company and senior in right of payment to all subordinated indebtedness of
the Company. 
 SECTION 2.06. Sinking Fund. The Notes will not be entitled to any sinking fund. 

ARTICLE III 
 REDEMPTION

 SECTION 3.01. Optional Redemption. 

(a) The 2026 Notes and the 2030 Notes are redeemable at the Company’s option, in whole or in part, at any time and from time to time prior
to the applicable Par Call Date, at a redemption price equal to the greater of: 
 (i) 100% of the principal amount of the Notes to be
redeemed; and 
 (ii) the sum of the present values of the Remaining Scheduled Payments of the Notes to be redeemed, discounted to the
applicable Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, plus 40 basis points, 

plus accrued and unpaid interest on the Notes being redeemed to, but excluding, the Redemption Date. 

(b) The Notes are redeemable at the Company’s option, in whole or in part, at any time and from time to time on or after the applicable
Par Call Date at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date. 

SECTION 3.02. General. 

(a) Notwithstanding Section 3.01, installments of interest on the Notes that are due and payable on any 2026 Interest Payment Date or 2030
Interest Payment Date, as the case may be, falling on or prior to a Redemption Date will be payable on such 2026 Interest Payment Date or 2030 Interest Payment Date to the registered Holders of the applicable series of Notes as of the close of
business on the relevant 2026 Regular Record Date or 2030 Regular Record Date, as the case may be, according to the terms of the Notes and the Indenture. Unless the Company 

  
 9 

 
defaults in payment of the redemption price, on and after the Redemption Date, interest will cease to accrue on any Notes or portions thereof that are called for redemption. 

(b) Notices of any optional redemption will be sent (or with respect to Global Notes, to the extent permitted or required by applicable DTC
procedures or regulations, sent electronically) at least 15 but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed at its registered address. The Company will also provide notice of any optional redemption to
the Trustee no later than the date such notice is sent to the Holders, which notice shall include the information required by the Original Indenture to be provided to the Holders in connection with the notice described in the immediately preceding
sentence. If the Company elects to have the Trustee give the notice, the Company shall notify the Trustee at least 5 days (unless a shorter period is agreed to by the Trustee) prior to the date notice is sent to Holders. The Company will calculate
the redemption price and will deliver an Officer’s Certificate to the Trustee setting forth the redemption price no later than two Business Days prior to the Redemption Date, and the Trustee will not be responsible for such calculation nor
shall the Trustee have any duty to monitor the accuracy of such calculations made by the Company which shall be conclusive and binding on the Holders, absent manifest error. 

(c) If less than all of either series of Notes are to be redeemed at any time, the Notes in the series to be redeemed will be selected in
minimum denominations of $2,000 in principal amount and integral multiples of $1,000 in excess thereof, in accordance with applicable DTC procedures, in the case of Global Notes, or by the Trustee by a method the Trustee deems to be fair and
appropriate, in the case of Notes that are not represented by a Global Note. 
 ARTICLE IV 

CHANGE OF CONTROL 

SECTION 4.01. Repurchase at the Option of Holders Upon a Change of Control Repurchase Event. 

(a) If a Change of Control Repurchase Event occurs with respect to either series of Notes, unless the Company has exercised its right to redeem
the Notes of such series pursuant to the Indenture, the Company shall make an offer to each Holder of such series of Notes to repurchase all or any part (in minimum denominations of $2,000 and integral multiples of $1,000 above that amount) of that
Holder’s Notes at a repurchase price in cash equal to 101% of the aggregate principal amount of the Notes repurchased plus any accrued and unpaid interest on the Notes repurchased to the date of repurchase. 

(b) Within 30 days following any Change of Control Repurchase Event or, at the option of the Company, prior to any Change of Control, but after
the public announcement of an impending Change of Control, the Company will send (or with respect to Global Notes, to the extent permitted or required by applicable DTC procedures or regulations, send electronically) a notice to each Holder of the
applicable series of Notes, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase such series of Notes on the payment date specified
in the notice, which date will be no earlier than 15 days and no later than 60 days from the date such notice is 

  
 10 

 
sent. The notice shall, if sent prior to the date of consummation of the Change of Control, state that the offer to repurchase is conditioned on the Change of Control Repurchase Event occurring
on or prior to the payment date specified in the notice. 
 (c) The Company will comply with the requirements of Rule 14e-1 under the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change
of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with this Article IV, the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached
its obligations under this Article IV by virtue of such conflict. 
 (d) On the Change of Control Repurchase Event payment date, the Company
will, to the extent lawful: 
 (i) accept for payment all the Notes or portions of the Notes (in minimum denominations of $2,000 and
integral multiples of $1,000 above that amount) properly tendered pursuant to its offer; 
 (ii) deposit on or before 10:00 a.m., New York
City time, with the Paying Agent an amount equal to the aggregate purchase price in respect of all the Notes or portions of the Notes properly tendered; and 

(iii) deliver or cause to be delivered to the Trustee the Notes properly tendered and accepted for repurchase, together with an Officer’s
Certificate stating the aggregate principal amount of Notes or portions of Notes being repurchased by the Company. 
 (e) The Paying Agent
will promptly deliver to each Holder of Notes properly tendered the purchase price for the Notes, and the Trustee will promptly authenticate and send (or, if a Global Note, cause to be transferred by book-entry) to each Holder a new Note equal in
principal amount to any unpurchased portion of any Notes surrendered; provided, that each new Note will be in a minimum principal amount of $2,000 or an integral multiple of $1,000 above that amount. 

(f) The Company will not be required to make an offer to repurchase the Notes upon a Change of Control Repurchase Event if a third party makes
such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company under this Article IV and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

ARTICLE V 
 TRANSFER AND
EXCHANGE 
 SECTION 5.01. Transfer and Exchange. For purposes of this Seventh Supplemental Indenture and the Notes,
Section 203(1) of the Original Indenture is replaced in its entirety by the following: 

  
 11 

 “SECTION 203. Transfer and Exchange. 

(1) Transfer and Exchange of Global Securities. A Global Security may not be transferred as a whole except by the Depository to a nominee of
the Depository, by a nominee of the Depository to the Depository or to another nominee of the Depository, or by the Depository or any such nominee to a successor Depository or a nominee of such successor Depository. The Company initially appoints
The Depository Trust Company (“DTC”) to act as Depository with respect to the Global Securities. Global Securities shall be exchanged by the Company for Definitive Securities if: 

(A) the Company delivers to the Trustee notice from the Depository that it is unwilling or unable to continue to act as
Depository for the Global Securities and a successor Depository is not appointed by the Company within 90 days after the date of such notice from the Depository; 

(B) the Company delivers to the Trustee notice from the Depository that it is no longer a clearing agency registered under the
Exchange Act; 
 (C) the Company, in its sole discretion and subject to the procedures of the Depository, determines that the
Global Securities (in whole but not in part) should be exchanged for Definitive Securities and delivers written notice to such effect to the Trustee; or 

(D) there shall have occurred and be continuing an Event of Default under this Indenture and the Trustee has received a request
from the Depository to issue Definitive Securities. 
 Upon the occurrence of any of the preceding events in (A), (B) or (C) above, the
Company will notify the Trustee in writing that, upon surrender by the Participants of their interest in such Global Securities, Definitive Securities will be issued to each Person that such Participants and the Depository identify as being the
beneficial owner of the related Securities. Beneficial interests in Global Securities may be exchanged for Definitive Securities of the same series upon request but only upon at least 30 days’ prior written notice given to the Trustee by or on
behalf of the Depository in accordance with customary procedures. Global Securities also may be exchanged or replaced, in whole or in part, as provided in Sections 304, 305 and 306 hereof. Except as otherwise provided above in this Section 203,
every Security authenticated and delivered in exchange for, or in lieu of, a Global Security or any portion thereof, pursuant to this Section 203 or Sections 304, 305 or 306 hereof, shall be authenticated and delivered in the form of, and shall
be, a Global Security. A Global Security may not be exchanged for another Security other than as provided in this Section 203(1).” 

  
 12 

 ARTICLE VI 

TRUSTEE 
 SECTION 6.01.
Corporate Trust Office. The Trustee is appointed as the principal paying agent, transfer agent and registrar for the Notes, including for the purposes of Section 1002 of the Original Indenture. The Notes may be presented for payment at
the Paying Agent Office of the Trustee or at any other agency as may be appointed from time to time by the Company in New York, New York or Chicago, Illinois. 

SECTION 6.02. Recitals of Fact; Certain Other Matters. The Trustee makes no representation as to, and shall not be responsible in any
manner whatsoever for or in respect of, the validity or sufficiency of this Seventh Supplemental Indenture or the due execution thereof by the Company, except for any certificate of authentication delivered in connection therewith. The recitals of
fact contained herein shall be taken as the statements solely of the Company and the Trustee assumes no responsibility for the correctness thereof. The Trustee shall not be accountable for the use or application by the Company of the proceeds from
the issuance of the Notes. All of the provisions contained in the Indenture in respect of the rights, powers, privileges, and immunities of the Trustee shall be applicable in respect of this Seventh Supplemental Indenture. The parties hereto
acknowledge that in accordance with the Customer Identification Program (CIP) requirements under the USA PATRIOT Act and its implementing regulations, the Trustee in order to help fight the funding of terrorism and money laundering, is required to
obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties hereby agree that they shall provide the Trustee with such information as it may
request including, but not limited to, each party’s name, physical address, tax identification number and other information that will help the Trustee identify and verify each party’s identity such as organizational documents, certificate
of good standing, license to do business, or other pertinent identifying information. 
 SECTION 6.03. Successor. Any corporation or
association into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation or association resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation or
association to which all or substantially all of the corporate trust business of the Trustee may be sold or otherwise transferred, shall be the successor trustee hereunder without any further act. 

ARTICLE VII 

MISCELLANEOUS PROVISIONS 

SECTION 7.01. Ratification of Original Indenture. This Seventh Supplemental Indenture is executed and shall be construed as an
indenture supplemental to the Original Indenture, and as supplemented and modified hereby, the Original Indenture is in all respects ratified and confirmed, and the Original Indenture and this Seventh Supplemental Indenture shall be read, taken and
construed as one and the same instrument. 

  
 13 

 SECTION 7.02. Effect of Headings. The Article and Section headings herein are for
convenience only and shall not affect the construction hereof. 
 SECTION 7.03. Successors and Assigns. All covenants and agreements
in this Seventh Supplemental Indenture by the Company shall bind its successors and assigns, whether so expressed or not. 
 SECTION 7.04.
Separability Clause. In case any one or more of the provisions contained in this Seventh Supplemental Indenture shall for any reason be held to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby. 
 SECTION 7.05. Governing Law. THIS SEVENTH
SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 SECTION 7.06.
Counterparts. This Seventh Supplemental Indenture may be executed in any number of counterparts, and each of such counterparts shall for all purposes be deemed to be an original, but all such counterparts shall together constitute one and the
same instrument. Signatures of the parties hereto transmitted by facsimile or PDF may be used in lieu of the originals and shall be deemed to be their original signatures for all purposes. 

  
 14 

 * * * * 

IN WITNESS WHEREOF, the parties hereto have caused this Seventh Supplemental Indenture to be duly executed as of the date first above written. 

 

					
	ZIMMER BIOMET HOLDINGS, INC.
			
	    	 	By:	 	         /s/ Suketu Upadhyay

		 		 	Name: Suketu Upadhyay
		 		 	 Title:   Executive Vice President and Chief

            Financial Officer

  

					
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Trustee
			
	    	 	By:	 	         /s/ Maddy Hughes

		 		 	Name: Maddy Hughes
		 		 	Title:   Vice President

 [Signature page to Seventh Supplemental Indenture – March 2020 Debt Offering] 

 EXHIBIT A 

FORM OF GLOBAL 2026 NOTE 

[FACE OF GLOBAL NOTE] 
 THIS GLOBAL
NOTE IS HELD BY AND REGISTERED IN THE NAME OF THE DEPOSITORY (AS DEFINED IN THE INDENTURE GOVERNING THIS SECURITY), IS NOT EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE EXCEPT IN THE LIMITED
CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (A) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO SECTION 203 OF THE INDENTURE, (B) THIS GLOBAL
NOTE MAY BE EXCHANGED PURSUANT TO SECTION 203(1) OF THE INDENTURE, (C) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 309 OF THE INDENTURE AND (D) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR
DEPOSITORY WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY
TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 CUSIP 98956P AS1 

ZIMMER BIOMET HOLDINGS, INC. 

$[                       
 ] 3.050% Notes due 2026 
  

			
	
$[                  
               ]
	  	No.: R-●

 Zimmer Biomet Holdings, Inc., a corporation duly organized and existing under the laws of the State of Delaware (herein called
the “Company”, which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE & CO., or registered assigns, the principal sum
of                                Dollars (or such other lesser or greater amount set
forth on the Schedule of Exchanges of Interests in the Global Security attached hereto) on January 15, 2026, and to pay interest thereon from March 20, 2020 or from the most recent Interest Payment Date to which interest has been paid or
duly provided 

  

$[                       
    ] 3.050% Note due 2026 
 A-1 

 
for, semi-annually on January 15 and July 15 each year, commencing on July 15, 2020, at the rate of 3.050% per annum, until the principal hereof is paid or made available for
payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at
the close of business on the Regular Record Date for such interest, which shall be the January 1 or the July 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so
punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of
business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holder of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any
time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
Indenture. 
 Payment of the principal of (and premium, if any) and any such interest on this Security will be made at the office or agency
of the Company maintained for that purpose at the Paying Agent Office of the Trustee, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided,
however, that at the option of the Company payment of interest may be sent to the address of the Person entitled thereto as such address shall appear in the Security Register. 

Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been executed by the
Trustee referred to on the reverse hereof by manual signature, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

  

$[                       
    ] 3.050% Note due 2026 
 A-2 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

 

					
	ZIMMER BIOMET HOLDINGS, INC.
			
	    	 	By:	 	  

		 		 	Name: Suketu Upadhyay
		 		 	 Title:   Executive Vice President and Chief

            Financial Officer

  

			
	Attest:	 	
	
	  

	Name:	 	Chad F. Phipps
	Title:	 	Senior Vice President, General Counsel and Secretary

  

$[                       
    ] 3.050% Note due 2026 
 A-3 

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

Dated: 
  

			
	Wells Fargo Bank, National Association, as Trustee
		
	By:	 	  

		 	Authorized Signatory

  

$[                       
    ] 3.050% Note due 2026 
 A-4 

 [FORM OF REVERSE OF NOTE] 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be
issued in one or more series under an Indenture, dated as of November 17, 2009 (the “Original Indenture”), as supplemented by the Seventh Supplemental Indenture thereto dated as of March 20, 2020 (the “Seventh Supplemental
Indenture” and together with the Original Indenture, the “Indenture”), between the Company and Wells Fargo Bank, National Association, as Trustee (herein called the “Trustee”, which term includes any successor trustee under
the Indenture), and reference is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which
the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, issued initially in an aggregate principal amount of $600,000,000. Terms defined in the Indenture and not defined
herein have the meanings ascribed thereto in the Indenture. 
 The Securities of this series are redeemable at the Company’s option, in
whole or in part, at any time and from time to time prior to December 15, 2025 at a redemption price equal to the greater of (i) 100% of the principal amount of the Securities of this series to be redeemed; and (ii) the sum of the present
values of the Remaining Scheduled Payments, discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the
Treasury Rate, plus 40 basis points, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date, in accordance with and pursuant to the terms and conditions set forth in the Indenture. 

The Securities of this series are redeemable at the Company’s option, in whole or in part, at any time and from time to time on or after
December 15, 2025 at a redemption price equal to 100% of the principal amount of the Securities of this series to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date, in accordance with and pursuant to
the terms and conditions set forth in the Indenture. 
 If a Change of Control Repurchase Event occurs, unless the Company has exercised its
right to redeem the Securities of this series pursuant to the Indenture, the Company will be required to make an offer to each Holder of the Securities of this series to repurchase all or any part (in minimum denominations of $2,000 and integral
multiples of $1,000 above that amount) of that Holder’s Securities of this series at a repurchase price in cash equal to 101% of the aggregate principal amount of such Securities repurchased plus any accrued and unpaid interest on such
Securities repurchased to the date of repurchase, in accordance with and pursuant to the terms and conditions set forth in the Indenture. 

The Indenture contains provisions for defeasance at any time of the entire Indebtedness of this Security or certain restrictive covenants and
Events of Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture. 
 If an
Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

  

$[                       
    ] 3.050% Note due 2026 
 A-5 

 The Indenture permits, with certain exceptions as therein provided, the amendment thereof
and the modification of the rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a
majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the
time Outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not
notation of such consent or waiver is made upon this Security. 
 As provided in and subject to the provisions of the Indenture, the Holder
of this Security shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee
written notice of a continuing Event of Default with respect to the Securities of this series, the Holders of not less than 25% in principal amount of the Securities of this series at the time Outstanding shall have made written request to the
Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee indemnity or security reasonably satisfactory to it, and the Trustee shall not have received from the Holders of a majority in principal amount
of Securities of this series at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall
not apply to any suit instituted by the Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 

No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security may be registered and this
Security may be exchanged as provided in the Indenture. 
 The Securities of this series are issuable only in registered form without
coupons in minimum denominations of $2,000 and any integral multiple of $1,000 in excess thereof. 
 No service charge shall be made for any
such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

  

$[                       
    ] 3.050% Note due 2026 
 A-6 

 All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture. To the extent any provision of this Security conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 

  

$[                       
    ] 3.050% Note due 2026 
 A-7 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 
 I or we
assign and transfer this Security to: 
  
  

(Insert assignee’s social security or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint                  as
agent to transfer this Security on the books of the Company. The agent may substitute another to act for him. 
  

 
  

			
	Your Signature:	  	  

		  	(Sign exactly as your name appears on the other side of this Security)

  

			
	Your Name:	  	  

Date:                        
 
  

			
	Signature Guarantee:	  	                                     
                                         
                                         
                                         
             *

  

	*	 NOTICE: The Signature must be guaranteed by an Institution which is a member of one of the following recognized
signature Guarantee Programs: (i) The Securities Transfer Agent Medallion Program (STAMP); (ii) The New York Stock Exchange Medallion Program (MNSP); (iii) The Stock Exchange Medallion Program (SEMP); or (iv) such other guarantee program
acceptable to the Trustee. 

  

$[                       
    ] 3.050% Note due 2026 
 A-8 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL SECURITY 

The following exchanges of an interest in this Global Security for an interest in another Global Security or for a Definitive Security, or
exchanges of an interest in another Global Security or a Definitive Security for an interest in this Global Security have been made: 
  

									
	 Date of Exchange
	 	 Amount of decrease

in Principal Amount of
 this
Global Security
	 	 Amount of increase

in Principal Amount of
 this
Global Security
	  	 Principal Amount of this

Global Security following

such decrease or increase
	  	 Signature of authorized

signatory or Trustee or

Securities Custodian

  

$[                       
    ] 3.050% Note due 2026 
 A-9 

 EXHIBIT B 

FORM OF GLOBAL 2030 NOTE 

[FACE OF GLOBAL NOTE] 
 THIS GLOBAL
NOTE IS HELD BY AND REGISTERED IN THE NAME OF THE DEPOSITORY (AS DEFINED IN THE INDENTURE GOVERNING THIS SECURITY), IS NOT EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE EXCEPT IN THE LIMITED
CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (A) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO SECTION 203 OF THE INDENTURE, (B) THIS GLOBAL
NOTE MAY BE EXCHANGED PURSUANT TO SECTION 203(1) OF THE INDENTURE, (C) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 309 OF THE INDENTURE AND (D) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR
DEPOSITORY WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY
TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 CUSIP 98956P AT9 

ZIMMER BIOMET HOLDINGS, INC. 

$[                       
 ] 3.550% Notes due 2030 
  

			
	$[                                 ]	  	No.: R-●

 Zimmer Biomet Holdings, Inc., a corporation duly organized and existing under the laws of the State of Delaware (herein called
the “Company”, which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE & CO., or registered assigns, the principal sum of
[                                 ] Dollars (or such other lesser or greater amount set
forth on the Schedule of Exchanges of Interests in the Global Security attached hereto) on March 20, 2030, and to pay interest thereon from March 20, 2020 or from the most recent Interest Payment Date to which interest has been paid or
duly provided for, 

  

$[                       
    ] 3.550% Note due 2030 
 B-1 

 
semi-annually on March 20 and September 20 each year, commencing on September 20, 2020, at the rate of 3.550% per annum, until the principal hereof is paid or made available for
payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at
the close of business on the Regular Record Date for such interest, which shall be the March 1 or the September 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so
punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of
business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holder of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any
time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
Indenture. 
 Payment of the principal of (and premium, if any) and any such interest on this Security will be made at the office or agency
of the Company maintained for that purpose at the Paying Agent Office of the Trustee, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided,
however, that at the option of the Company payment of interest may be sent to the address of the Person entitled thereto as such address shall appear in the Security Register. 

Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been executed by the
Trustee referred to on the reverse hereof by manual signature, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

  

$[                       
    ] 3.550% Note due 2030 
 B-2 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

 

			
	ZIMMER BIOMET HOLDINGS, INC.
		
	    By:	 	  

		 	Name: Suketu Upadhyay
		 	 Title:   Executive Vice President and Chief

            Financial Officer

 Attest: 
  

			
	  

	Name:	 	Chad F. Phipps
	Title:	 	Senior Vice President, General Counsel and Secretary

  

$[                       
    ] 3.550% Note due 2030 
 B-3 

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

Dated: 
  

			
	Wells Fargo Bank, National Association, as Trustee
		
	By:	 	  

		 	Authorized Signatory

  

$[                       
    ] 3.550% Note due 2030 
 B-4 

 [FORM OF REVERSE OF NOTE] 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be
issued in one or more series under an Indenture, dated as of November 17, 2009 (the “Original Indenture”), as supplemented by the Seventh Supplemental Indenture thereto dated as of March 20, 2020 (the “Seventh Supplemental
Indenture” and together with the Original Indenture, the “Indenture”), between the Company and Wells Fargo Bank, National Association, as Trustee (herein called the “Trustee”, which term includes any successor trustee under
the Indenture), and reference is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which
the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, issued initially in an aggregate principal amount of $900,000,000. Terms defined in the Indenture and not defined
herein have the meanings ascribed thereto in the Indenture. 
 The Securities of this series are redeemable at the Company’s option, in
whole or in part, at any time and from time to time prior to December 20, 2029 at a redemption price equal to the greater of (i) 100% of the principal amount of the Securities of this series to be redeemed; and (ii) the sum of the present
values of the Remaining Scheduled Payments, discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the
Treasury Rate, plus 40 basis points, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date, in accordance with and pursuant to the terms and conditions set forth in the Indenture. 

The Securities of this series are redeemable at the Company’s option, in whole or in part, at any time and from time to time on or after
December 20, 2029 at a redemption price equal to 100% of the principal amount of the Securities of this series to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date, in accordance with and pursuant to
the terms and conditions set forth in the Indenture. 
 If a Change of Control Repurchase Event occurs, unless the Company has exercised its
right to redeem the Securities of this series pursuant to the Indenture, the Company will be required to make an offer to each Holder of the Securities of this series to repurchase all or any part (in minimum denominations of $2,000 and integral
multiples of $1,000 above that amount) of that Holder’s Securities of this series at a repurchase price in cash equal to 101% of the aggregate principal amount of such Securities repurchased plus any accrued and unpaid interest on such
Securities repurchased to the date of repurchase, in accordance with and pursuant to the terms and conditions set forth in the Indenture. 

The Indenture contains provisions for defeasance at any time of the entire Indebtedness of this Security or certain restrictive covenants and
Events of Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture. 
 If an
Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

  

$[                       
    ] 3.550% Note due 2030 
 B-5 

 The Indenture permits, with certain exceptions as therein provided, the amendment thereof
and the modification of the rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a
majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the
time Outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not
notation of such consent or waiver is made upon this Security. 
 As provided in and subject to the provisions of the Indenture, the Holder
of this Security shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee
written notice of a continuing Event of Default with respect to the Securities of this series, the Holders of not less than 25% in principal amount of the Securities of this series at the time Outstanding shall have made written request to the
Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee indemnity or security reasonably satisfactory to it, and the Trustee shall not have received from the Holders of a majority in principal amount
of Securities of this series at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall
not apply to any suit instituted by the Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 

No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security may be registered and this
Security may be exchanged as provided in the Indenture. 
 The Securities of this series are issuable only in registered form without
coupons in minimum denominations of $2,000 and any integral multiple of $1,000 in excess thereof. 
 No service charge shall be made for any
such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

  

$[                       
    ] 3.550% Note due 2030 
 B-6 

 All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture. To the extent any provision of this Security conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 

  

$[                       
    ] 3.550% Note due 2030 
 B-7 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 
 I or we assign
and transfer this Security to: 
  
  

(Insert assignee’s social security or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint ________as agent to transfer this Security on the books of the Company. The agent may substitute another to
act for him. 
  
  

 

			
	Your Signature:	 	
                     
    

		 	(Sign exactly as your name appears on the other side of this Security)

			
	Your Name:	 	
                     

Date:                        

  

					
	Signature Guarantee:	 	
                     
    
	  	*

  

	*	 NOTICE: The Signature must be guaranteed by an Institution which is a member of one of the following recognized
signature Guarantee Programs: (i) The Securities Transfer Agent Medallion Program (STAMP); (ii) The New York Stock Exchange Medallion Program (MNSP); (iii) The Stock Exchange Medallion Program (SEMP); or (iv) such other guarantee program
acceptable to the Trustee. 

  

$[                       
    ] 3.550% Note due 2030 
 B-8 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL SECURITY 

The following exchanges of an interest in this Global Security for an interest in another Global Security or for a Definitive Security, or
exchanges of an interest in another Global Security or a Definitive Security for an interest in this Global Security have been made: 
  

									
	 Date of Exchange
	 	 Amount of decrease

in Principal Amount of

this Global Security
	 	 Amount of increase

in Principal Amount of
 this
Global Security
	  	 Principal Amount of this

Global Security following

such decrease or increase
	  	 Signature of authorized

signatory or Trustee or

Securities Custodian

  

$[                       
    ] 3.550% Note due 2030 
 B-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]